Drug
Midazolam Injectable Solution
Midazolam Injectable Solution is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_4
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 42 (66.7%)
Trials by Status
terminated133%
unknown133%
completed133%
Recent Activity
Clinical Trials (3)
Showing 3 of 3 trials
NCT05469204Phase 4
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT04955470Phase 1
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics
NCT03534895Phase 4
Does the Preoperative Midazolam Dose Affect Postoperative Pain?
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3